Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Shilpa Medicare Limited ( (IN:SHILPAMED) ) just unveiled an update.
Shilpa Medicare Limited announced the reclassification of two shareholders, Mr. Suraj Kumar Inani and Ms. Priya Inani, from the ‘Promoter Group’ category to the ‘Public’ category, following approval from the BSE. This reclassification, which involves a total of 4.09% of the company’s shares, reflects a strategic move in compliance with SEBI regulations, potentially impacting the company’s shareholder structure and market perception.
More about Shilpa Medicare Limited
Shilpa Medicare Limited operates in the pharmaceutical industry, focusing on the development and manufacturing of affordable healthcare products. The company is known for its commitment to innovation in the healthcare sector, providing a range of pharmaceutical products to meet diverse medical needs.
Average Trading Volume: 5,575
Technical Sentiment Signal: Buy
Current Market Cap: 79.46B INR
Find detailed analytics on SHILPAMED stock on TipRanks’ Stock Analysis page.